1.Risk Factors of Cardiovascular Disease according to Alcohol Behavioral Change after Cancer Diagnosis
Eun Mi BAE ; In Young CHO ; Ji-Hye JUN ; Kiheon LEE ; Ju Young KIM ; Woo Kyung BAE ; Hyejin LEE ; Jong Soo HAN ; Se Young JUNG ; Kee Hyuck LEE ; Sarah KIM ; Hye Yeon KOO ; Sang Jin CHO ; Houbuem LEE ; Chuelmin PAEK
Korean Journal of Family Medicine 2020;41(4):222-228
Background:
Problem drinking increases the incidence of all-cause mortality and specific cancers, and persistent drinking is associated with cardiovascular disease in certain cancer survivors. This study analyzed the cardiovascular risk factors before and after diagnosis in Korean cancer survivors.
Methods:
Data for the period between 2002 and 2013 were collected from the National Health Insurance Service Health-Examinee Cohort Database. Among the 27,835 patients included, those with moderate alcohol consumption before and after cancer diagnosis were excluded. Problem drinking was defined as males under 65 years consuming over 14 glasses a week, and males over 65 years or females consuming over seven glasses a week. A t-test, chi-square test, and linear regression analysis were performed for differences in cardiovascular risk factors and differences according to cancer types.
Results:
There was a difference in the body mass index, systolic and diastolic blood pressure, and total cholesterol among patients who became moderate drinkers after diagnosis, but fasting blood glucose did not show any significant changes. Risk factors for cardiovascular disease were analyzed in patients with liver, stomach, rectal, and breast cancer with improved drinking behavior, and there were significant differences in body mass index, systolic and diastolic blood pressure, fasting blood glucose, and total cholesterol in stomach cancer patients.
Conclusion
Moderate drinking can lower cardiovascular risk in cancer survivors, and among the many drinking-related cancers, stomach cancer patients demonstrated significantly reduced cardiovascular risk factors.
2.Prediction of lymph node metastasis in patients with apparent early endometrial cancer.
Joo Hyuk SON ; Tae Wook KONG ; Su Hyun KIM ; Jiheum PAEK ; Suk Joon CHANG ; Eun Ju LEE ; Hee Sug RYU
Obstetrics & Gynecology Science 2015;58(5):385-390
OBJECTIVE: The purpose of this study is to investigate the incidence of lymph node metastasis in early endometrial cancer patients and to evaluate preoperative clinicopathological factors predicting lymph node metastasis. METHODS: We identified 142 patients with endometrial cancer between January 2000 and February 2013. All patients demonstrated endometrioid adenocarcinoma with grade 1 or 2 on preoperative endometrial biopsy. Preoperative magnetic resonance imaging showed that tumors were confined to the uterine corpus with superficial myometrial invasion (less than 50%), and there were no lymph nodes enlargements. All patients had complete staging procedures and were surgically staged according to the 2009 FIGO (International Federation of Gynecology and Obstetrics) staging system. Clinical and pathological data were obtained from medical records and statistically analyzed. RESULTS: Of the 142 patients, 127 patients (89.4%) presented with stage 1A, 8 (5.6%) with stage IB, 3 (2.1%) with stage II, and 4 (2.8%) with stage III disease. Three patients (2.1%) had lymph node metastasis-2 IIIC1 and 1 IIIC2 disease. Age, preoperative tumor grade, and myometrial invasion less than 50% on preoperative MRI were not associated with lymph node metastasis. A high preoperative serum CA-125 level (>35 IU/mL) was a statistically significant factor for predicting lymph node metastasis on univariate and multivariate analyses. Lymph node metastasis was only found in patients with preoperative grade 2 tumors or a high serum CA-125 level. CONCLUSION: Preoperative tumor grade and serum CA-125 level can predict lymph node metastasis in apparent early endometrial cancer patients.
Biopsy
;
Carcinoma, Endometrioid
;
Endometrial Neoplasms*
;
Female
;
Gynecology
;
Humans
;
Incidence
;
Lymph Nodes*
;
Magnetic Resonance Imaging
;
Medical Records
;
Multivariate Analysis
;
Neoplasm Metastasis*
3.Garlic powder intake and cardiovascular risk factors: a meta-analysis of randomized controlled clinical trials.
Jin Sook KWAK ; Ji Yeon KIM ; Ju Eun PAEK ; You Jin LEE ; Haeng Ran KIM ; Dong Sik PARK ; Oran KWON
Nutrition Research and Practice 2014;8(6):644-654
BACKGROUND/OBJECTIVES: Although preclinical studies suggest that garlic has potential preventive effects on cardiovascular disease (CVD) risk factors, clinical trials and reports from systematic reviews or meta-analyses present inconsistent results. The contradiction might be attributed to variations in the manufacturing process that can markedly influence the composition of garlic products. To investigate this issue further, we performed a meta-analysis of the effects of garlic powder on CVD risk factors. MATERIALS/METHODS: We searched PubMed, Cochrane, Science Direct and EMBASE through May 2014. A random-effects meta-analysis was performed on 22 trials reporting total cholesterol (TC), 17 trials reporting LDL cholesterol (LDL-C), 18 trials reporting HDL cholesterol (HDL-C), 4 trials reporting fasting blood glucose (FBG), 9 trials reporting systolic blood pressure (SBP) and 10 trials reporting diastolic blood pressure (DBP). RESULTS: The overall garlic powder intake significantly reduced blood TC and LDL-C by -0.41 mmol/L (95% confidence interval [CI], -0.69, -0.12) (-15.83 mg/dL [95% CI, -26.64, -4.63]) and -0.21 mmol/L (95% CI, -0.40, -0.03) (-8.11 mg/dL [95% CI, -15.44, -1.16]), respectively. The mean difference in the reduction of FBG levels was -0.96 mmol/L (95% CI, -1.91, -0.01) (-17.30 mg/dL [95% CI, -34.41, -0.18]). Evidence for SBP and DBP reduction in the garlic supplementation group was also demonstrated by decreases of -4.34 mmHg (95% CI, -8.38, -0.29) and -2.36 mmHg (95% CI, -4.56, -0.15), respectively. CONCLUSIONS: This meta-analysis provides consistent evidence that garlic powder intake reduces the CVD risk factors of TC, LDL-C, FBG and BP.
Blood Glucose
;
Blood Pressure
;
Cardiovascular Diseases
;
Cholesterol
;
Cholesterol, HDL
;
Cholesterol, LDL
;
Fasting
;
Garlic*
;
Risk Factors*
4.Proposed Motor Scoring System in a Porcine Model of Parkinson's Disease induced by Chronic Subcutaneous Injection of MPTP.
Joon Ho MOON ; Ji Ho KIM ; Hyung Jun IM ; Dong Soo LEE ; Eun Jung PARK ; Kilyoung SONG ; Hyun Ju OH ; Su Bin HYUN ; Sang Chul KANG ; Hyunil KIM ; Hyo Eun MOON ; Hyung Woo PARK ; Hong Jae LEE ; Eun Ji KIM ; Seokjoong KIM ; Byeong Chun LEE ; Sun Ha PAEK
Experimental Neurobiology 2014;23(3):258-265
Destruction of dopaminergic neurons in the substantia nigra pars compacta (SNpc) is a common pathophysiology of Parkinson's disease (PD). Characteristics of PD patients include bradykinesia, muscle rigidity, tremor at rest and disturbances in balance. For about four decades, PD animal models have been produced by toxin-induced or gene-modified techniques. However, in mice, none of the gene-modified models showed all 4 major criteria of PD. Moreover, distinguishing between PD model pigs and normal pigs has not been well established. Therefore, we planned to produce a pig model for PD by chronic subcutaneous administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), neurotoxin. Changes in behavioral patterns of pigs were thoroughly evaluated and a new motor scoring system was established for this porcine model that was based on the Unified Parkinson's Disease Rating Scale (UPDRS) in human PD patients. In summary, this motor scoring system could be helpful to analyze the porcine PD model and to confirm the pathology prior to further examinations, such as positron emission tomography-computed tomography (PET-CT), which is expensive, and invasive immunohistochemistry (IHC) of the brain.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine*
;
Animals
;
Brain
;
Dopaminergic Neurons
;
Electrons
;
Humans
;
Hypokinesia
;
Immunohistochemistry
;
Injections, Subcutaneous*
;
Mice
;
Models, Animal
;
Muscle Rigidity
;
Parkinson Disease*
;
Pathology
;
Substantia Nigra
;
Swine
;
Tremor
5.Systematic review of the effect of dried ginger powder on improvement of nausea and vomiting associated with early pregnancy or motion sickness.
Jin Sook KWAK ; Ju Eun PAEK ; Sewon JEONG ; Joohee KIM ; Ji Yeon KIM ; Oran KWON
Journal of Nutrition and Health 2014;47(1):45-50
PURPOSE: Ginger (Zingiber officinale) has been widely used as an antiemetic agent. This systematic review was aimed at evaluation of the effect of dried ginger powder supplementation on improvement of nausea and vomiting associated with early pregnancy or motion sickness. METHODS: We searched Pubmed, Cochrane, Science Direct, and KISS (Korean studies Information Service System) using keywords such as ginger or Zingiber officinale in combination with nausea, vomiting, motion sickness, or pregnancy, published in March 2013. RESULTS: The strength of the evidence was evaluated on the selected 12 RCTs (randomized controlled trials). Eleven trials including 2,630 subjects showed that supplementation with dried ginger powder resulted in significant improvement of nausea or vomiting related to early pregnancy or motion sickness. Among the nine studies including 809 women in early pregnancy before 20 weeks of gestation, ginger supplementation was superior to placebo in five studies (n = 305), and as effective as positive control (vitamin B6 or dimenhydrinate) in four studies (n = 504). Ginger intake significantly reduced the episodes or severity of vomiting related to motion sickness compared to placebo or showed the same effect as several antiemetic drugs in two studies (n = 1,821). CONCLUSION: Our findings added evidence indicating that ginger powder supplements might improve the symptoms of nausea or vomiting related to early pregnancy or motion sickness without significant adverse events.
Antiemetics
;
Female
;
Ginger*
;
Humans
;
Information Services
;
Morning Sickness
;
Motion Sickness*
;
Nausea*
;
Pregnancy*
;
Vomiting*
6.Systematic review of the effect of omega-3 fatty acids on improvement of blood flow while focused on evaluation of claims for health functional food.
Sewon JEONG ; Ji Yeon KIM ; Ju Eun PAEK ; Joohee KIM ; Jin Sook KWAK ; Oran KWON
Journal of Nutrition and Health 2013;46(3):226-238
Omega-3 polyunsaturated fatty acids are essential fatty acids because humans cannot synthesize them de novo and must obtain them in their diet. Fish and fish oil are rich sources of omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Significant evidence of the beneficial role of dietary intake of omega-3 fatty acids in blood flow has been reported and putative mechanisms for improvement of blood flow include anti-thrombotic effects, lowered blood pressure, improved endothelial function, and anti-atherogenic effects. Edible oils containing omega-3 fatty acids were registered as functional ingredients in the Korea Health Functional Food Code. Although omega-3 fatty acids have been evaluated by the Korea Food and Drug Administration (KFDA) based on scientific evidence, periodic re-evaluation may be needed because emerging data related to omega-3 fatty acids have accumulated. Therefore, in this study, we re-evaluated scientific evidence for the effect of omega-3 fatty acids as a functional ingredient in health functional food on improvement of blood flow. A comprehensive literature search was conducted for collection of relevant human studies using the Medline and Cochrane, KISS, and IBIDS databases for the years 1955-2012. Search keywords were used by combination of terms related to omega-3 fatty acids and blood flow. The search was limited to human studies published in Korean, English, and Japanese. Using the KFDA's evidence based evaluation system for scientific evaluation of health claims, 112 human studies were identified and reviewed in order to evaluate the strength of the evidence supporting a relation between omega-3 fatty acids and blood flow. Among 112 studies, significant effects on improvement of blood flow were reported in 84 studies and the daily intake amount was ranged from 0.1 to 15 g. According to this methodology of systematic review, we concluded that there was possible evidence to support a relation between omega-3 fatty acid intake and blood flow. However, because inconsistent results have recently been reported, future studies should be monitored.
Asian Continental Ancestry Group
;
Blood Pressure
;
Diet
;
Eicosapentaenoic Acid
;
Fatty Acids, Essential
;
Fatty Acids, Omega-3
;
Fatty Acids, Unsaturated
;
Functional Food
;
Humans
;
Korea
;
Oils
;
United States Food and Drug Administration
7.Systematic review of the effect of coenzyme Q10 on antioxidant capacity while focused on evaluation of claims for health functional food.
Ji Yeon KIM ; Sewon JEONG ; Ju Eun PAEK ; Joohee KIM ; Jin Sook KWAK ; Yoon Jung LEE ; Tae Seok KANG ; Oran KWON
Journal of Nutrition and Health 2013;46(3):218-225
Although the functional ingredient has been evaluated by the Korea Food and Drug Administration (KFDA) based on scientific evidence, the levels of scientific evidence and consistency of the results might vary according to emerging data. Therefore, periodic re-evaluation may be needed for some functional ingredients. In this study, we re-evaluated scientific evidence for the antioxidant activity of coenzyme Q10 as a functional ingredient in health functional food. Literature searches were conducted using the Medline and Cochrane, KISS, and IBIDS databases for the years 1955-2010 with the search term of coenzyme Q10 in combination with antioxidant. The search was limited to human studies published in Korean, English, and Japanese. Using the KFDA's evidence based evaluation system for scientific evaluation of health claims, 33 human studies were identified and reviewed in order to evaluate the strength of the evidence supporting a relation between coenzyme Q10 and antioxidant activity. Among 33 studies, significant effects for antioxidant activities were reported in 22 studies and their daily intake amount was 60 to 300 mg. Based on this systematic review, we concluded that there was possible evidence to support a relation between coenzyme Q10 intake and antioxidant activities. However, because inconsistent results have recently been reported, future studies should be monitored.
Asian Continental Ancestry Group
;
Functional Food
;
Humans
;
Korea
;
Ubiquinone
;
United States Food and Drug Administration
8.Comparison for Risk Estimate of Aspiration between the Revised Dysphagia Assessment Tool and Videofluoroscopy in Post-Stroke Patients.
Kyung Hee MOON ; Hyun Sook SOHN ; Eun Seok LEE ; Eun Kyung PAEK ; Eun Ju KANG ; Seung Hee LEE ; Na Ri HAN ; Meen Hye LEE ; Deog Young KIM ; Chang Gi PARK ; Ji Soo YOO
Journal of Korean Academy of Nursing 2010;40(3):359-366
PURPOSE: The purpose of this study was to determine the significant factors for risk estimate of aspiration and to evaluate the efficiency of the dysphagia assessment tool. METHODS: A consecutive series of 210 stroke patients with aspiration symptoms such as cough and dysphagia who had soft or regular diet without tube feeding were examined. The dysphagia assessment tool for aspiration was compared with videofluoroscopy using Classification and Regression Tree (CART) analysis. RESULTS: In CART analysis, of 34 factors, the significant factors for estimating risk of aspiration were cough during swallowing, oral stasis, facial symmetry, salivary drooling, and cough after swallowing. The risk estimate error of the revised dysphagia assessment tool was 25.2%, equal to that of videofluoroscopy. CONCLUSION: The results indicate that the dysphagia assessment tool developed and examined in this study was potentially useful in the clinical field and the primary risk estimating factor was cough during swallowing. Oral stasis, facial symmetry, salivary drooling, cough after swallowing were other significant factors, and based on these results, the dysphagia assessment tool for aspiration was revised and complemented.
Adult
;
Aged
;
Cough
;
Deglutition
;
Deglutition Disorders/complications/*diagnosis
;
Facial Asymmetry
;
Female
;
Fluoroscopy/methods
;
Humans
;
Inhalation
;
Male
;
Middle Aged
;
Risk Assessment
;
Stroke/*complications/radiography/therapy
9.3-year Follow-up of a Menkes Disease Patient.
Ju Hee YOU ; Hyun PAEK ; Kwon JUNG ; Gyu Keun SUN ; Han Wook YOO ; Kyoung Sim KIM ; Yong Wook KIM ; Eun Young KIM
Journal of the Korean Child Neurology Society 2007;15(1):94-101
Menkes disease is a rare fatal X-linked recessive disorder characterized by a generalized defect in intracelluar copper transport. The clinical features which arise from copper deficiency include progressive neurologic deterioration, epilepsy, hair and connective tissue abnormalities. Menkes disease is caused by mutations in the gene encoding the Menkes protein(ATP7A, copper transporting P-type ATPase), which is located on the long arm 13 of the X-chromosome. ATP7A mutations are found in 60 to 70% of the patients. We have experienced a case of Menkes disease in a 6-month-old male who showed developmental delay, myoclonic seizures and kinky hair. The serum copper and ceruloplasmin levels were low and the missense mutation(c.3352G>A, resulting in p.G1118S) in exon 17 of ATP7A gene was found. During 3-year follow-up, he regressed developmentally and showed brain atrophy, multiple bladder deverticula, and bony deformities.
Arm
;
Atrophy
;
Brain
;
Ceruloplasmin
;
Congenital Abnormalities
;
Connective Tissue
;
Copper
;
Epilepsy
;
Exons
;
Follow-Up Studies*
;
Hair
;
Humans
;
Infant
;
Male
;
Menkes Kinky Hair Syndrome*
;
Seizures
;
Urinary Bladder
10.Nitric oxide production and inducible nitric oxide synthase expression induced by Porphyromonas gingivalis lipopolysaccharide.
Eun Young PAEK ; Eun Young CHOI ; Jeom Il CHOI ; Ju Yun LEE ; Sung Jo KIM
The Journal of the Korean Academy of Periodontology 2005;35(4):1081-1095
No abstract available.
Nitric Oxide Synthase Type II*
;
Nitric Oxide*
;
Porphyromonas gingivalis*
;
Porphyromonas*

Result Analysis
Print
Save
E-mail